TITLE:
Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes

CONDITION:
Diabetes

INTERVENTION:
insulin detemir

SUMMARY:

      This trial is conducted in Europe and the United States of America (USA). The purpose of
      this study is to test whether insulin detemir is a safe and at least as effective
      alternative to insulin glargine for the control of blood glucose in basal/bolus therapy in
      patients with type 2 diabetes.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Type 2 diabetes for at least 12 months

          -  Treated with oral antidiabetic drugs or with any insulin regimen with or without oral
             antidiabetic drugs

          -  BMI of maximum 40 kg/m2

          -  HbA1c greater than or equal to 7.0% and less than or equal to 11.0%

        Exclusion Criteria:

          -  Proliferative retinopathy or maculopathy

          -  Recurrent major hypoglycaemia

          -  Impaired hepatic or renal function

          -  Cardiac problems or uncontrolled hypertension
      
